Daichi Shimbo

Daichi Shimbo

Auto-generated profile, based on publicly available information

Daichi Shimbo

Columbia University Irving Medical Center

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 November 2015 in Annals of Internal Medicine
Verified
Journal Article
Closed access
DSDaichi Shimbo
Daichi Shimbo
MAMarwah Abdalla
Marwah Abdalla
LFLouise Falzon
Louise Falzon
RTRaymond R. Townsend
Raymond R. Townsend
PMPaul Muntner
Paul Muntner
This review describes ambulatory blood pressure monitoring (ABPM) and home blood pressure monitoring (HBPM), the blood pressure phenotypic measurements that can be ascertained, and the evidence tha... Hypertension, a common risk factor for cardiovascular disease, is usually diagnosed and treated based on blood pressure readings obtained in the clinic setting. Blood pressure may differ considerab...

4 January 2022 in Annals of Internal Medicine
Verified
Journal Article
Closed access
AKAlka M. Kanaya
Alka M. Kanaya
AHAnn W Hsing
Ann W Hsing
SPSela V. Panapasa
Sela V. Panapasa
NKNamratha R. Kandula
Namratha R. Kandula
MAMaria Rosario G. Araneta
Maria Rosario G. Araneta
YHYuling Hong
Yuling Hong
This special article summarizes findings from a 3-day multidisciplinary workshop, hosted by the National Institutes of Health to identify research opportunities for advancing prevention and care an... Asian Americans (AsA), Native Hawaiians, and Pacific Islanders (NHPI) comprise 7.7% of the U.S. population, and AsA have had the fastest growth rate since 2010. Yet the National Institutes of Healt...

1 March 2023 in Hypertension
Verified
Journal Article
Closed access
PDF file
MGMichelle L. Gumz
Michelle L. Gumz
DSDaichi Shimbo
Daichi Shimbo
MAMarwah Abdalla
Marwah Abdalla
RBRavi C. Balijepalli
Ravi C. Balijepalli
Christian BenedictChristian Benedict
Christian Benedict
YOYoung S. Oh
Young S. Oh
Healthy individuals exhibit blood pressure variation over a 24-hour period with higher blood pressure during wakefulness and lower blood pressure during sleep. Loss or disruption of the blood pressure circadian rhythm has been linked to adverse health outcomes, for example, cardiovascular disease, dementia, and chronic kidney disease. However, the current diagnostic and therapeutic approaches lack sufficient attention to the circadian rhythmicity of blood pressure. Sleep patterns, hormone release, eating habits, digestion, body temperature, renal and cardiovascular function, and other important host functions as well as gut microbiota exhibit circadian rhythms, and influence circadian rhythms of blood pressure. Potential benefits of nonpharmacologic interventions such as meal timing, and pharmacologic chronotherapeutic interventions, such as the bedtime administration of antihypertensive medications, have recently been suggested in some studies. However, the mechanisms underlying circadian rhythm-mediated blood pressure regulation and the efficacy of chronotherapy in hypertension remain unclear. This review summarizes the results of the National Heart, Lung, and Blood Institute workshop convened on October 27 to 29, 2021 to assess knowledge gaps and research opportunities in the study of circadian rhythm of blood pressure and chronotherapy for hypertension.

1 May 2016 in Circulation: Cardiovascular Quality and Outcomes
Verified
Journal Article
Closed access
PDF file
DSDaichi Shimbo
Daichi Shimbo
CBC. Barrett Bowling
C. Barrett Bowling
ELEmily B. Levitan
Emily B. Levitan
LDLuqin Deng
Luqin Deng
JSJohn J. Sim
John J. Sim
PMPaul Muntner
Paul Muntner
Background—: Antihypertensive medication use has been associated with an increased risk of falls in some but not all studies. Few data are available on the short-term risk of falls after antihypertensive medication initiation and intensification. Methods and Results—: We examined the association between initiating and intensifying antihypertensive medication and serious fall injuries in a case-crossover study of 90 127 Medicare beneficiaries who were ≥65 years old and had a serious fall injury between July 1, 2007, and December 31, 2012, based on emergency department and inpatient claims. Antihypertensive medication initiation was defined by a prescription fill with no fills in the previous year. Intensification was defined by the addition of a new antihypertensive class, and separately, titration by the addition of a new class or increase in dosage of a current class. Exposures were ascertained for the 15 days before the fall (case period) and six 15-day earlier periods (control periods). Overall, 272, 1508, and 3113 Medicare beneficiaries initiated, added a new class of antihypertensive medication or titrated therapy within 15 days of their serious fall injury. The odds for a serious fall injury was increased during the 15 days after antihypertensive medication initiation (odds ratio, 1.36 [95% confidence interval, 1.19–1.55]), adding a new class (odds ratio, 1.16 [95% confidence interval, 1.10–1.23]), and titration [odds ratio, 1.13 [95% confidence interval, 1.08–1.18]). These associations were attenuated beyond 15 days. Conclusions—: Antihypertensive medication initiation and intensification was associated with a short-term, but not long-term, increased risk of serious fall injuries among older adults.

1 March 2016 in Journal of the American Society of Hypertension
Verified
Journal Article
Closed access
DSDaichi Shimbo
Daichi Shimbo
MAMarwah Abdalla
Marwah Abdalla
LFLouise Falzon
Louise Falzon
RTRaymond R. Townsend
Raymond R. Townsend
PMPaul Muntner
Paul Muntner

18 July 2023 in Journal of the American Heart Association
Verified
Journal Article
Open access
TSTariq Jamal Siddiqi
Tariq Jamal Siddiqi
MUMuhammad Shariq Usman
Muhammad Shariq Usman
ARAhmed Mustafa Rashid
Ahmed Mustafa Rashid
SJSyed Sarmad Javaid
Syed Sarmad Javaid
AAAymen Ahmed
Aymen Ahmed
MHMichael E. Hall
Michael E. Hall
Background: To study the prevalence and types of hypertension‐mediated organ damage and the prognosis of patients presenting to the emergency department (ED) with hypertensive emergencies. Methods and Results: PubMed was queried from inception through November 30, 2021. Studies were included if they reported the prevalence or prognosis of hypertensive emergencies in patients presenting to the ED. Studies reporting data on hypertensive emergencies in other departments were excluded. The extracted data were arcsine transformed and pooled using a random‐effects model. Fifteen studies (n=4370 patients) were included. Pooled analysis demonstrates that the prevalence of hypertensive emergencies was 0.5% (95% CI, 0.40%–0.70%) in all patients presenting to ED and 35.9% (95% CI, 26.7%–45.5%) among patients presenting in ED with hypertensive crisis. Ischemic stroke (28.1% [95% CI, 18.7%–38.6%]) was the most prevalent hypertension‐mediated organ damage, followed by pulmonary edema/acute heart failure (24.1% [95% CI, 19.0%–29.7%]), hemorrhagic stroke (14.6% [95% CI, 9.9%–20.0%]), acute coronary syndrome (10.8% [95% CI, 7.3%–14.8%]), renal failure (8.0% [95% CI, 2.9%–15.5%]), subarachnoid hemorrhage (6.9% [95% CI, 3.9%–10.7%]), encephalopathy (6.1% [95% CI, 1.9%–12.4%]), and the least prevalent was aortic dissection (1.8% [95% CI, 1.1%–2.8%]). Prevalence of in‐hospital mortality among patients with hypertensive emergency was 9.9% (95% CI, 1.4%–24.6%). Conclusions: Our findings demonstrate a pattern of hypertension‐mediated organ damage primarily affecting the brain and heart, substantial cardiovascular renal morbidity and mortality, as well as subsequent hospitalization in patients with hypertensive emergencies presenting to the ED.